Lopinavir plus nucleoside reverse-transcriptase inhibitors, lopinavir plus raltegravir, or lopinavir...
Lopinavir plus nucleoside reverse-transcriptase inhibitors, lopinavir plus raltegravir, or lopinavir monotherapy for second-line treatment of HIV (EARNEST): 144-week follow-up results from a randomised controlled trial
About this item
Full title
Author / Creator
Thompson, Jennifer , Kityo, Cissy , Kambugu, Andrew , Lugemwa, Abbas , Mwebaze, Raymond , Thomason, Margaret J , Mugyenyi, Peter , Walker, A Sarah , Bakeinyaga, G , Kasuswa, S , Mulima, D , Musana, H , Namata, H , Nkalubo, J , Okello, P , Pimundu, G , Segonga, P , Ssali, F , Kayiwa, J , Tukamushaba, J , Abunyang, S , Lwalanda, R , Namusanje, J , Katwere, M , Komujuni, C , Matovu, J , Nakajubi, A , Nalumenya, R , Semitala, F , Ssenkindu, T , Acaku, M , Ssebutinde, P , Kukundakwe, J , Naluguza, M , Nsibuka, F , Fortunate, M , Acen, J , Achidri, J , Chamai, M , Kiconco, M , Matama, C , Nambaziira, F , Rweyora, A , Tumwebaze, G , Kiyingi, A , Senoga, I , Abwola, M , Mudoola, M , Ssennono, F , Amone, G , Arach, B , Bekusike, G , Bulegyeya, A , Nassali, A , Ndukukire , Ntawiha, H , Rogers, A , Kiirya, S , Balmoi, F , Kafuma, S , Phiri, M , Mudzingwa, S , Bafana, T , Chitongo, S , Lifa, Linly , Musowa, George , Mwimaniwa, Grace , Sikwese, Rosemary , Ziwoya, Milton , Kamanga, S , Makwakwa, T Kayinga E , Mlenga, M , Mphande, T , Mtika, C , Nyirenda, R , Mudogo, A , Wools-Kaloustian, K , Kunda, I , Mufwambi, W , Mulenga, L , Namfukwe, M , Kerukadho, E , Ngwatu, B , Tebbs, S , Whittle, J , Wilkes, H , Kyomuhendo, F , Mkandawire, N , Senyonjo, S , Angus, B , Palfreeman, A , Arribas, J , Floridia, M , Walsh, P , De Rosa, M , Gilks, C , Kangewende, A , van Wyk, J , Lehrman, S , Rooney, J and Europe Africa Research Network for Evaluation of Second-line Therapy (EARNEST) Trial Team
Publisher
United States: Elsevier Ltd
Journal title
Language
English
Formats
Publication information
Publisher
United States: Elsevier Ltd
Subjects
More information
Scope and Contents
Contents
Millions of HIV-infected people worldwide receive antiretroviral therapy (ART) in programmes using WHO-recommended standardised regimens. Recent WHO guidelines recommend a boosted protease inhibitor plus raltegravir as an alternative second-line combination. We assessed whether this treatment option offers any advantage over the standard protease i...
Alternative Titles
Full title
Lopinavir plus nucleoside reverse-transcriptase inhibitors, lopinavir plus raltegravir, or lopinavir monotherapy for second-line treatment of HIV (EARNEST): 144-week follow-up results from a randomised controlled trial
Authors, Artists and Contributors
Author / Creator
Kityo, Cissy
Kambugu, Andrew
Lugemwa, Abbas
Mwebaze, Raymond
Thomason, Margaret J
Mugyenyi, Peter
Walker, A Sarah
Bakeinyaga, G
Kasuswa, S
Mulima, D
Musana, H
Namata, H
Nkalubo, J
Okello, P
Pimundu, G
Segonga, P
Ssali, F
Kayiwa, J
Tukamushaba, J
Abunyang, S
Lwalanda, R
Namusanje, J
Katwere, M
Komujuni, C
Matovu, J
Nakajubi, A
Nalumenya, R
Semitala, F
Ssenkindu, T
Acaku, M
Ssebutinde, P
Kukundakwe, J
Naluguza, M
Nsibuka, F
Fortunate, M
Acen, J
Achidri, J
Chamai, M
Kiconco, M
Matama, C
Nambaziira, F
Rweyora, A
Tumwebaze, G
Kiyingi, A
Senoga, I
Abwola, M
Mudoola, M
Ssennono, F
Amone, G
Arach, B
Bekusike, G
Bulegyeya, A
Nassali, A
Ndukukire
Ntawiha, H
Rogers, A
Kiirya, S
Balmoi, F
Kafuma, S
Phiri, M
Mudzingwa, S
Bafana, T
Chitongo, S
Lifa, Linly
Musowa, George
Mwimaniwa, Grace
Sikwese, Rosemary
Ziwoya, Milton
Kamanga, S
Makwakwa, T Kayinga E
Mlenga, M
Mphande, T
Mtika, C
Nyirenda, R
Mudogo, A
Wools-Kaloustian, K
Kunda, I
Mufwambi, W
Mulenga, L
Namfukwe, M
Kerukadho, E
Ngwatu, B
Tebbs, S
Whittle, J
Wilkes, H
Kyomuhendo, F
Mkandawire, N
Senyonjo, S
Angus, B
Palfreeman, A
Arribas, J
Floridia, M
Walsh, P
De Rosa, M
Gilks, C
Kangewende, A
van Wyk, J
Lehrman, S
Rooney, J
Europe Africa Research Network for Evaluation of Second-line Therapy (EARNEST) Trial Team
Identifiers
Primary Identifiers
Record Identifier
TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_5739875
Permalink
https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_5739875
Other Identifiers
ISSN
1473-3099
E-ISSN
1474-4457
DOI
10.1016/S1473-3099(17)30630-8
